-+ 0.00%
-+ 0.00%
-+ 0.00%

U.S. FDA APPROVES GILEAD’S BIXLENVO™, A NEW ONCE-DAILY SINGLE TABLET OPTION FOR VIROLOGICALLY SUPPRESSED ADULTS WITH HIV, INCLUDING THOSE ON COMPLEX REGIMENS

Reuters·08/27/2026 21:47:00

Please log in to view news